Twist Bioscience

Twist Bioscience Corporation (TWST) – Ready for break-even with positive EPS?

in , , on December 7, 2022

This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations.

Twist Bioscience Corporation (TWST)

The company has been alleged to have high cash burning ratio. It is experiencing cash burn issues despite a strong balance sheet.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– Economic Value Analysis
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

CrispIdea Coverage

No of Pages : 29

Release Information

  • Price
    :

    $99.00

  • Released
    :

    December 7, 2022

  • Last Updated
    :

    December 8, 2022